Skip to main content
. 2019 Aug 14;2019(8):CD001016. doi: 10.1002/14651858.CD001016.pub3
# Query Results
S24 S11 AND S23 61
S23 S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 1,301,554
S22 TX allocat* random* 9,763
S21 (MH "Quantitative Studies") 21,772
S20 (MH "Placebos") 11,101
S19 TX placebo* 55,070
S18 TX random* allocat* 9,763
S17 (MH "Random Assignment") 53,035
S16 TX randomi* control* trial* 163,662
S15 TX ( (singl* n1 blind*) or (singl* n1 mask*) ) or TX ( (doubl* n1 blind*) or (doubl* n1 mask*) ) or TX ( (tripl* n1 blind*) or (tripl* n1 mask*) ) or TX ( (trebl* n1 blind*) or (trebl* n1 mask*) ) 1,000,920
S14 TX clinic* n1 trial* 238,474
S13 PT Clinical trial 86,722
S12 (MH "Clinical Trials+") 254,738
S11 S6 AND S10 165
S10 S7 OR S8 OR S9 10,573
S9 TX(progestagen* or progestational) 2,226
S8 TX(Progestin* or progestogen* or progesterone or norethisterone or norethindrone or dydrogesterone or medroxyprogesterone) 9,546
S7 (MM "Progestational Hormones+") 2,192
S6 S1 OR S2 OR S3 OR S4 OR S5 1,606
S5 TX heavy N5 menstrua* 460
S4 TX hypermenorrh* 24
S3 TX (dysfunctional N5 uter*) 134
S2 TX menorrhag* 1,284
S1 (MM "Menorrhagia") 691